Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Heart Transplantation

  Free Subscription


Articles published in Transplantation

Retrieve available abstracts of 104 articles:
HTML format



Single Articles


    June 2021
  1. FITZSIMONS SJ, Evans JDW, Rassl DM, Lee KK, et al
    High-Sensitivity Cardiac Troponin is not Associated with Acute Cellular Rejection after Heart Transplantation.
    Transplantation. 2021 Jun 29. doi: 10.1097/TP.0000000000003876.
    PubMed     Abstract available


    April 2021
  2. LOZANO-EDO S, Sanchez-Lazaro I, Portoles M, Rosello-Lleti E, et al
    Plasma Levels of SERCA2a as a Noninvasive Biomarker of Primary Graft Dysfunction After Heart Transplantation.
    Transplantation. 2021 Apr 23. pii: 00007890-900000000-95272.
    PubMed     Abstract available


  3. AGUILAR J, Miller RJ, Otaki Y, Tamarappoo B, et al
    Clinical Utility of SPECT in the Heart Transplant Population: Analysis from a Single Large-Volume Center.
    Transplantation. 2021 Apr 21. pii: 00007890-900000000-95267.
    PubMed     Abstract available


    March 2021
  4. MARCONDES-BRAGA FG, Murad CM, Belfort DSP, Dantas RCT, et al
    Characteristics and Outcomes of Heart Transplant Recipients with Coronavirus-19 Disease in A High-Volume Transplant Center.
    Transplantation. 2021 Mar 22. pii: 00007890-900000000-95294.
    PubMed     Abstract available


  5. EISEN HJ
    Primum non Nocere: Induction in Kidney Transplantation After Heart Transplantation.
    Transplantation. 2021 Mar 19. pii: 00007890-900000000-95297.
    PubMed    


  6. RIAD S, Alexy T, Jackson S, Goswami U, et al
    Kidney Allograft and Recipient Survival After Heart Transplantation by Induction Type in the United States.
    Transplantation. 2021 Mar 19. pii: 00007890-900000000-95295.
    PubMed     Abstract available


  7. AGUILERA AGUDO C, Gomez Bueno M, Krsnik Castello I
    Daratumumab for Antibody-mediated Rejection in Heart Transplant-A Novel Therapy: Successful Treatment of Antibody-mediated Rejection.
    Transplantation. 2021;105:e30-e31.
    PubMed    


  8. WELLS MA, See Hoe LE, Heather LC, Molenaar P, et al
    Peritransplant Cardiometabolic and Mitochondrial Function: The Missing Piece in Donor Heart Dysfunction and Graft Failure.
    Transplantation. 2021;105:496-508.
    PubMed     Abstract available


  9. DEW MA, Hollenberger JC, Obregon LL, Hickey GW, et al
    The Preimplantation Psychosocial Evaluation and Prediction of Clinical Outcomes During Mechanical Circulatory Support: What Information Is Most Prognostic?
    Transplantation. 2021;105:608-619.
    PubMed     Abstract available


    February 2021
  10. MORENO JD, Verma AM, Kopecky BJ, Dehner C, et al
    Angiotensin II Type 1 Receptor Antibody Mediated Rejection Following Orthotopic Heart Transplant: A Single Center Experience.
    Transplantation. 2021 Feb 22. doi: 10.1097/TP.0000000000003712.
    PubMed     Abstract available


  11. HUCKABY LV, Seese LM, Handzel R, Wang Y, et al
    Center-level Utilization of Hepatitis C Virus Positive Donors for Orthotopic Heart Transplantation.
    Transplantation. 2021 Feb 8. doi: 10.1097/TP.0000000000003674.
    PubMed     Abstract available


  12. AILI SR, De Silva R, Wilhelm K, Jha SR, et al
    Validation of Cognitive Impairment in Combination With Physical Frailty as a Predictor of Mortality in Patients With Advanced Heart Failure Referred for Heart Transplantation.
    Transplantation. 2021 Feb 5. doi: 10.1097/TP.0000000000003669.
    PubMed     Abstract available


    January 2021
  13. EPAILLY E
    New Onset Diabetes After Heart Transplantation: A Call to Arms.
    Transplantation. 2021 Jan 25. pii: 00007890-900000000-95408.
    PubMed    


  14. FUJISAKI T, Mikami T, Kuno T, Moss N, et al
    Effect of Hepatitis C Virus Infection on Heart Transplants in the Current Era.
    Transplantation. 2021 Jan 25. pii: 00007890-900000000-95404.
    PubMed     Abstract available


  15. VEST AR, Cherikh WS, Noreen SM, Stehlik J, et al
    New Onset Diabetes Mellitus After Adult Heart Transplantation and the Risk of Renal Dysfunction or Mortality.
    Transplantation. 2021 Jan 25. pii: 00007890-900000000-95403.
    PubMed     Abstract available


  16. HUCKABY LV, Hickey G, Sultan I, Kilic A, et al
    Improvements in Functional Status Among Survivors of Orthotopic Heart Transplantation Following High-risk Bridging Modalities.
    Transplantation. 2021 Jan 7. doi: 10.1097/TP.0000000000003602.
    PubMed     Abstract available


    December 2020
  17. ROSS-DRISCOLL K, Axelrod D, Lynch R, Patzer RE, et al
    Using Geographic Catchment Areas to Measure Population-based Access to Kidney Transplant in the United States.
    Transplantation. 2020;104:e342-e350.
    PubMed     Abstract available


  18. JORDAN SC, Ammerman N, Choi J, Kumar S, et al
    Interleukin-6: An Important Mediator of Allograft Injury.
    Transplantation. 2020;104:2497-2506.
    PubMed     Abstract available


    November 2020
  19. BUTTS RJ, Baez Hernandez N, Kirk R, Bano M, et al
    Center Donor Refusal Rate is Associated With Worse Outcomes After Listing in Pediatric Heart Transplantation.
    Transplantation. 2020 Nov 2. doi: 10.1097/TP.0000000000003514.
    PubMed     Abstract available


  20. AFZAL AM, Meyer DM
    The Dark Side of Chasing the Perfect Donor. Is It Time for Us to Change Cardiac Transplant Program Performance Metrics?
    Transplantation. 2020 Nov 2. doi: 10.1097/TP.0000000000003515.
    PubMed    


    September 2020
  21. RIBEIRO RVP, Alvarez JS, Yu F, Adamson MB, et al
    Comparing Donor Heart Assessment Strategies During Ex Situ Heart Perfusion to Better Estimate Posttransplant Cardiac Function.
    Transplantation. 2020;104:1890-1898.
    PubMed     Abstract available


    August 2020
  22. IANNINO N, Fischer K, Friedrich M, Hafyane T, et al
    Myocardial Vascular Function Assessed by Dynamic Oxygenation-sensitive Cardiac Magnetic Resonance Imaging Long-term Following Cardiac Transplantation.
    Transplantation. 2020 Aug 13. doi: 10.1097/TP.0000000000003419.
    PubMed     Abstract available


    July 2020
  23. ZHENG H, Su Y, Zhu C, Quan D, et al
    An Addition of U0126 Protecting Heart Grafts From Prolonged Cold Ischemia Reperfusion Injury in Heart Transplantation: A New Preservation Strategy.
    Transplantation. 2020 Jul 27. doi: 10.1097/TP.0000000000003402.
    PubMed     Abstract available


    May 2020
  24. CHEN J, Miao X, Liu C, Liu B, et al
    BET protein inhibition prolongs cardiac transplant survival via enhanced yocardial autophagy.
    Transplantation. 2020 May 18. doi: 10.1097/TP.0000000000003319.
    PubMed     Abstract available


  25. MULTANI A, Moayedi Y, Puing A, Henricksen E, et al
    Recent Trends of Infectious Complications Following Heart Transplantation.
    Transplantation. 2020 May 11. doi: 10.1097/TP.0000000000003307.
    PubMed     Abstract available


    March 2020
  26. SEE HOE LE, Wells MA, Bartnikowski N, Obonyo NG, et al
    Heart Transplantation From Brain Dead Donors: A Systematic Review of Animal Models.
    Transplantation. 2020 Mar 5. doi: 10.1097/TP.0000000000003217.
    PubMed     Abstract available


  27. SPITALERI G, Farrero M
    Translational Medicine in Brain Stem Death and Heart Transplantation.
    Transplantation. 2020 Mar 3. doi: 10.1097/TP.0000000000003218.
    PubMed    


    February 2020
  28. MILLS MF, Long J, Qin F, Collins RT, et al
    A Predictive Model for Intracardiac Pressures in Patients Free from Rejection or Allograft Vasculopathy After Pediatric Heart Transplantation.
    Transplantation. 2020 Feb 10. doi: 10.1097/TP.0000000000003166.
    PubMed     Abstract available


  29. KUMAR A, Howard A, Thomas CP
    Estimated Glomerular Filtration Rate at Transplant Listing and Other Predictors of Post-Heart Transplant Mortality and the Development of ESRD.
    Transplantation. 2020 Feb 5. doi: 10.1097/TP.0000000000003159.
    PubMed     Abstract available


  30. BLAZQUEZ-BERMEJO Z, Hernandez-Afonso J, Garcia-Quintana A, Medina JM, et al
    Heart Transplantation in a Distant Island Population: Accessibility and Outcomes in Patients From the Canary Islands Transplanted in Madrid.
    Transplantation. 2020;104:223-226.
    PubMed    


    January 2020
  31. YU MD, Liebo MJ, Lundgren S, Salim AM, et al
    Impaired Exercise Tolerance Early After Heart Transplantation Is Associated With Development of Cardiac Allograft Vasculopathy.
    Transplantation. 2020 Jan 3. doi: 10.1097/TP.0000000000003110.
    PubMed     Abstract available


  32. MACDONALD P
    Calcineurin Inhibitor-free Maintenance Immunosuppression After Heart Transplantation-Are We There Yet?
    Transplantation. 2020;104:13-14.
    PubMed    


  33. OH NA, O'Shea T, Ndishabandi DK, Yuan Q, et al
    Plasmacytoid Dendritic Cell-driven Induction of Treg Is Strain Specific and Correlates With Spontaneous Acceptance of Kidney Allografts.
    Transplantation. 2020;104:39-53.
    PubMed     Abstract available


    December 2019
  34. QUE W, Hu X, Fujino M, Terayama H, et al
    Prolonged cold ischemia time in mouse heart transplantation using supercooling preservation.
    Transplantation. 2019 Dec 30. doi: 10.1097/TP.0000000000003089.
    PubMed     Abstract available


  35. CONNOLLY SM, Granger E, Hayward C, Huang D, et al
    LONG-TERM OUTCOME IN SEVERE LEFT VENTRICULAR PRIMARY GRAFT DYSFUNCTION POST CARDIAC TRANSPLANTATION SUPPORTED BY EARLY USE OF EXTRACORPOREAL MEMBRANE OXYGENATION.
    Transplantation. 2019 Dec 27. doi: 10.1097/TP.0000000000003094.
    PubMed     Abstract available


    October 2019
  36. KLIMCZAK-TOMANIAK D, Roest S, Brugts JJ, Caliskan K, et al
    THE ASSOCIATION BETWEEN CYTOMEGALOVIRUS INFECTION AND CARDIAC ALLOGRAFT VASCULOPATHY IN THE ERA OF ANTIVIRAL VALGANCICLOVIR PROPHYLAXIS.
    Transplantation. 2019 Oct 21. doi: 10.1097/TP.0000000000003015.
    PubMed     Abstract available


  37. MACDONALD P
    Calcineurin inhibitor-free maintenance immunosuppression after heart transplantation - are we there yet?
    Transplantation. 2019 Oct 17. doi: 10.1097/TP.0000000000003008.
    PubMed    


    September 2019
  38. PANAGOU E, Ellery P, Martyn-Simmons C, Perrett C, et al
    A case of hidroacanthoma simplex in a cardiac transplant recipient.
    Transplantation. 2019 Sep 30. doi: 10.1097/TP.0000000000002988.
    PubMed    


  39. ASIMACOPOULOS EP, Garbern JC, Gauvreau K, Blume ED, et al
    Association of Clinical Rejection vs. Rejection on Protocol Biopsy with Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients.
    Transplantation. 2019 Sep 24. doi: 10.1097/TP.0000000000002983.
    PubMed     Abstract available


  40. PARK S, Lee JG, Jang JY, Ryu JH, et al
    Induction of Accommodation by Anti-complement Component 5 Antibody-based Immunosuppression in ABO-incompatible Heart Transplantation.
    Transplantation. 2019;103:e248-e255.
    PubMed     Abstract available


    August 2019
  41. JENNINGS DL, Jackson R, Farr M
    PCSK9 Inhibitor Use in Heart Transplant Recipients: A Case Series and Review of the Literature.
    Transplantation. 2019 Aug 29. doi: 10.1097/TP.0000000000002944.
    PubMed    


  42. SEGURO LFBC, Pereira RMR, Seguro LPC, Caparbo VF, et al
    Bone metabolism impairment in heart transplant: results from a prospective cohort study.
    Transplantation. 2019 Aug 8. doi: 10.1097/TP.0000000000002906.
    PubMed     Abstract available


    July 2019
  43. DI NORA C, Paldino A, Miani D, Finato N, et al
    Heart transplantation in Kearns-Sayre syndrome.
    Transplantation. 2019 Jul 12. doi: 10.1097/TP.0000000000002860.
    PubMed    


  44. NIKOLOVA AP, Kobashigawa JA
    Cardiac Allograft Vasculopathy: The Enduring Enemy of Cardiac Transplantation.
    Transplantation. 2019;103:1338-1348.
    PubMed     Abstract available


    May 2019
  45. OWADA Y, Oshiro Y, Inagaki Y, Harada H, et al
    A Nationwide Survey of Hepatitis E Virus Infection and Chronic Hepatitis in Heart and Kidney Transplant Recipients in Japan.
    Transplantation. 2019 May 20. doi: 10.1097/TP.0000000000002801.
    PubMed     Abstract available


    April 2019
  46. LATUS H, Hachmann P, Voges I, Mueller S, et al
    Reduced biventricular volumes and myocardial dysfunction long-term after pediatric heart transplantation assessed by CMR.
    Transplantation. 2019 Apr 4. doi: 10.1097/TP.0000000000002738.
    PubMed     Abstract available


  47. URAIZEE I, Varma VK, Sreedhar H, Gambacorta F, et al
    Label-free Identification of Antibody-mediated Rejection in Cardiac Allograft Biopsies Using Infrared Spectroscopic Imaging.
    Transplantation. 2019;103:698-704.
    PubMed     Abstract available


    March 2019
  48. GUSTAFSSON F, Andreassen AK, Andersson B, Eiskjaer H, et al
    S1Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Long-term Follow-up From the Randomized SCHEDULE Study.
    Transplantation. 2019 Mar 12. doi: 10.1097/TP.0000000000002702.
    PubMed     Abstract available


  49. NIKOLOVA AP, Kobashigawa JA
    Cardiac allograft vasculopathy-the enduring enemy of cardiac transplantation.
    Transplantation. 2019 Mar 6. doi: 10.1097/TP.0000000000002704.
    PubMed     Abstract available


    February 2019
  50. CHOUDHRY S, Wang Y, Denfield SW, Cabrera AG, et al
    A Recipient Risk Prediction Tool for Short Term Mortality after Pediatric Heart Transplantation.
    Transplantation. 2019 Feb 19. doi: 10.1097/TP.0000000000002679.
    PubMed     Abstract available


  51. AVTAAR SINGH SS, Banner NR, Rushton S, Simon AR, et al
    ISHLT Primary Graft Dysfunction Incidence, Risk Factors, and Outcome: A UK National Study.
    Transplantation. 2019;103:336-343.
    PubMed     Abstract available


    January 2019
  52. FUKUNAGA N, Bissoondath V, Rao V
    A custom made clamp facilitating stabilization of cuffs in murine heterotopic cervical heart transplantation.
    Transplantation. 2019 Jan 30. doi: 10.1097/TP.0000000000002582.
    PubMed    


    November 2018
  53. DI NORA C, Sponga S, Livi U
    Safety and efficacy of PCSK9 inhibitor treatment in heart transplant patients.
    Transplantation. 2018 Nov 5. doi: 10.1097/TP.0000000000002520.
    PubMed    


    October 2018
  54. COUTANCE G, d'Orio V, Belin L, Brechot N, et al
    Favorable outcome of an exclusively posttransplant prophylactic strategy after heart transplantation in recipients with high immunological risk.
    Transplantation. 2018 Oct 30. doi: 10.1097/TP.0000000000002503.
    PubMed     Abstract available


  55. IUS F, Haverich A, Warnecke G
    Cardiac transplantation across preformed HLA-antibody barriers.
    Transplantation. 2018 Oct 26. doi: 10.1097/TP.0000000000002504.
    PubMed    


    September 2018
  56. SCHNUELLE P, Benck U, Kramer BK
    DONOR HYPOTHERMIA AND HEART TRANSPLANTATION.
    Transplantation. 2018 Sep 21. doi: 10.1097/TP.0000000000002447.
    PubMed    


  57. SILVA HT JUNIOR
    The challenges associated with a calcineurin inhibitor free regimen after heart transplantation.
    Transplantation. 2018 Sep 21. doi: 10.1097/TP.0000000000002444.
    PubMed    


  58. ANDREASSEN AK, Broch K, Eiskjaer H, Karason K, et al
    Blood Pressure in De novo Heart Transplant Recipients Treated with Everolimus Compared with a Cyclosporine-Based Regimen: Results from the Randomized SCHEDULE Trial.
    Transplantation. 2018 Sep 11. doi: 10.1097/TP.0000000000002445.
    PubMed     Abstract available


  59. WANG ZM, Wang MJ, Hu XF, Li YK, et al
    Liraglutide, a Glucagon-Like Peptide-1 Receptor Agonist, Attenuates Development of Cardiac Allograft Vasculopathy in a Murine Heart Transplant Model.
    Transplantation. 2018 Sep 10. doi: 10.1097/TP.0000000000002448.
    PubMed     Abstract available


    August 2018
  60. HSU WT, Lin CH, Jui HY, Tseng YH, et al
    CXCR4 Antagonist Reduced the Incidence of Acute Rejection and Controlled Cardiac Allograft Vasculopathy in a Swine Heart Transplant Model Receiving a Mycophenolate-Based Immunosuppressive Regimen.
    Transplantation. 2018 Aug 8. doi: 10.1097/TP.0000000000002404.
    PubMed     Abstract available


  61. FUKUNAGA N, Bissoondath V, Rao V
    Submandibular Gland-preserving Technique for Heterotopic Cervical Heart Transplantation in Mice.
    Transplantation. 2018 Aug 6. doi: 10.1097/TP.0000000000002395.
    PubMed    


    July 2018
  62. SCHNUELLE P, Benck U, Kramer BK, Yard BA, et al
    Impact of Donor Core Body Temperature on Graft Survival After Heart Transplantation.
    Transplantation. 2018 Jul 10. doi: 10.1097/TP.0000000000002337.
    PubMed     Abstract available


  63. GARCIA-GIGORRO R, Renes-Carreno E, Corres-Peiretti MA, Arribas-Lopez P, et al
    Incidence, Risk Factors and Outcomes of Early Acute Kidney Injury After Heart Transplantation: An 18-year Experience.
    Transplantation. 2018 Jul 4. doi: 10.1097/TP.0000000000002293.
    PubMed     Abstract available


  64. BADER F, Atallah B, Rizk J, AlHabeeb W, et al
    Heart Transplantation in the Middle East Gulf Region.
    Transplantation. 2018;102:1023-1026.
    PubMed    


    June 2018
  65. ZHANG Q, Hickey M, Drogalis-Kim D, Zheng Y, et al
    Understanding the correlation between DSA, complement activation and antibody mediated rejection in heart transplant recipients.
    Transplantation. 2018 Jun 18. doi: 10.1097/TP.0000000000002333.
    PubMed     Abstract available


  66. BIBAS L, Saleh E, Al-Kharji S, Chetrit J, et al
    Muscle Mass and Mortality After Cardiac Transplantation.
    Transplantation. 2018 Jun 6. doi: 10.1097/TP.0000000000002311.
    PubMed     Abstract available


  67. MASTROBUONI S, Dell'Aquila AM, Van Caenegem O, Poncelet A, et al
    Do Patients Supported With Continuous-flow Left Ventricular Assist Device Have a Sufficient Risk of Death to Justify a Priority Allocation? A Propensity Score Matched Analysis of Patients Listed in UNOS Status 2.
    Transplantation. 2018;102:e288-e294.
    PubMed     Abstract available


    May 2018
  68. MACERA F, Occhi L, Masciocco G, Varrenti M, et al
    A new life: motherhood after heart transplantation. A single center experience and review of literature.
    Transplantation. 2018 May 14. doi: 10.1097/TP.0000000000002281.
    PubMed     Abstract available


  69. POTENA L, Moriconi V, Presta E
    Pregnancy and Heart Transplantation: Giving Birth After a New Life.
    Transplantation. 2018 May 14. doi: 10.1097/TP.0000000000002282.
    PubMed    


  70. SHAO EX, Wang CSW, Javorsky G
    Parvovirus B19 induced red cell aplasia in a heart transplant patient diagnosed on pleural fluid.
    Transplantation. 2018 May 14. doi: 10.1097/TP.0000000000002277.
    PubMed    


    April 2018
  71. GODOWN J, Thurm C, Hall M, Soslow JH, et al
    Changes in pediatric heart transplant hospitalization costs over time.
    Transplantation. 2018 Apr 19. doi: 10.1097/TP.0000000000002202.
    PubMed     Abstract available


  72. ROSENBAUM AN, Abou Ezzeddine OF, Grogan M, Dispenzieri A, et al
    Outcomes after Cardiac Transplant for Wild Type Transthyretin Amyloidosis.
    Transplantation. 2018 Apr 19. doi: 10.1097/TP.0000000000002240.
    PubMed     Abstract available


    March 2018
  73. PEYSTER EG, Madabhushi A, Margulies KB
    Advanced Morphologic Analysis for Diagnosing Allograft Rejection: The Case of Cardiac Transplant Rejection.
    Transplantation. 2018 Mar 22. doi: 10.1097/TP.0000000000002189.
    PubMed     Abstract available


  74. JACOBSEN MC, Manunta MDI, Pincott ES, Fenton M, et al
    Specific Immunity to Cytomegalovirus in Pediatric Cardiac Transplantation.
    Transplantation. 2018 Mar 5. doi: 10.1097/TP.0000000000002157.
    PubMed     Abstract available


  75. ZHANG T, Azimzadeh AM, Sun W, O'Neill NA, et al
    Selective CD28 Inhibition Modulates Alloimmunity and Cardiac Allograft Vasculopathy in Anti-CD154-Treated Monkeys.
    Transplantation. 2018;102:e90-e100.
    PubMed     Abstract available


    February 2018
  76. ZUCKERMANN A, Osorio-Jamillio E, Aliabadi-Zuckermann AZ
    mTOR Inhibition and Clinical Transplantation: Heart.
    Transplantation. 2018;102.
    PubMed     Abstract available


    January 2018
  77. PELED Y, Kassif Y, Kogan A, Freimark D, et al
    Heart Transplantation in a Left Ventricular Assist Device Recipient Following Donor's Extracorporeal Membrane Oxygenation Support: Is it safe?
    Transplantation. 2018 Jan 10. doi: 10.1097/TP.0000000000002059.
    PubMed    


    December 2017
  78. MORATH C, Opelz G, Dohler B, Zeier M, et al
    Influence of Blood Pressure and Calcineurin Inhibitors on Kidney Function After Heart or Liver Transplantation.
    Transplantation. 2017 Dec 5. doi: 10.1097/TP.0000000000002023.
    PubMed     Abstract available


  79. FANTUS D, Dai H, Ono Y, Watson A, et al
    Influence of the Novel ATP-Competitive Dual mTORC1/2 Inhibitor AZD2014 on Immune Cell Populations and Heart Allograft Rejection.
    Transplantation. 2017;101:2830-2840.
    PubMed     Abstract available


    November 2017
  80. TROTTER PB, Summers DM, Ushiro-Lumb I, Robb M, et al
    Use of organs from hepatitis C virus positive donors for uninfected recipients: a potential cost-effective approach to save lives?
    Transplantation. 2017 Nov 22. doi: 10.1097/TP.0000000000002033.
    PubMed     Abstract available


  81. GREY ST, Issa F
    The 2017 Transplantation Awards: Recognizing a Landmark Clinical Trial and a Basic Science Discovery With Far-Reaching Implications.
    Transplantation. 2017;101:2655-2656.
    PubMed    


    October 2017
  82. BRYANT R RD, Rizwan R, Zafar F, Shah SA, et al
    CONTEMPORARY OUTCOMES OF COMBINED HEART-LIVER TRANSPLANT IN PATIENTS WITH CONGENITAL HEART DISEASE.
    Transplantation. 2017 Oct 26. doi: 10.1097/TP.0000000000001978.
    PubMed     Abstract available


  83. LI T, Lee W, Hara H, Long C, et al
    An Investigation of Extracellular Histones in Pig-To-Baboon Organ Xenotransplantation.
    Transplantation. 2017;101:2330-2339.
    PubMed     Abstract available


    September 2017
  84. POTENA L, Pellegrini C, Grigioni F, Amarelli C, et al
    Optimizing the Safety Profile of Everolimus by Delayed Initiation in De Novo Heart Transplant Recipients: Results of the Prospective Randomized Study EVERHEART.
    Transplantation. 2017 Sep 19. doi: 10.1097/TP.0000000000001945.
    PubMed     Abstract available


  85. DAS BB, Lacelle C, Zhang S, Gao A, et al
    Complement (C1q) Binding De Novo Donor Specific Antibodies and Cardiac-Allograft Vasculopathy in Pediatric Heart Transplant Recipients.
    Transplantation. 2017 Sep 6. doi: 10.1097/TP.0000000000001944.
    PubMed     Abstract available


  86. O'NEILL NA, Zhang T, Braileanu G, Sun W, et al
    Comparative Evaluation of alphaCD40 (2C10R4) and alphaCD154 (5C8H1 and IDEC-131) in a Nonhuman Primate Cardiac Allotransplant Model.
    Transplantation. 2017;101:2038-2047.
    PubMed     Abstract available


    August 2017
  87. KEARNS MJ, Miller SD, Cheung A, Bashir J, et al
    A Rodent Model of Cardiac Donation After Circulatory Death and Novel Biomarkers of Cardiac Viability During Ex Vivo Heart Perfusion.
    Transplantation. 2017;101:e231-e239.
    PubMed     Abstract available


    June 2017
  88. POTENA L, Khush KK
    The Conundrum of Equitable Organ Allocation in Heart Transplantation: The Moving Target of Candidate Risk Score.
    Transplantation. 2017 Jun 6. doi: 10.1097/TP.0000000000001841.
    PubMed    


    May 2017
  89. CHEN Y, Zhang L, Liu J, Zhang P, et al
    Molecular Imaging of Acute Cardiac Transplant Rejection: Animal Experiments and Prospects.
    Transplantation. 2017 May 19. doi: 10.1097/TP.0000000000001780.
    PubMed     Abstract available


  90. MACDONALD P
    Heart Transplantation From DCD Donors: From the Bedside to the Bench.
    Transplantation. 2017 May 17. doi: 10.1097/TP.0000000000001829.
    PubMed    


  91. PASUPNETI S, Dhillon G, Reitz B, Khush K, et al
    Combined heart lung transplantation: an updated review of the current literature.
    Transplantation. 2017 May 13. doi: 10.1097/TP.0000000000001820.
    PubMed     Abstract available


    March 2017
  92. JASSERON C, Legeai C, Jacquelinet C, Leprince P, et al
    Prediction of Waitlist Mortality in Adult Heart Transplant Candidates: The Candidate Risk Score.
    Transplantation. 2017 Mar 8. doi: 10.1097/TP.0000000000001724.
    PubMed     Abstract available


  93. WEI L, Kaul V, Qu X, Xiong X, et al
    Absence of miR-182 Augments Cardiac Allograft Survival.
    Transplantation. 2017;101:524-530.
    PubMed     Abstract available


    February 2017
  94. NELSON LM, Andreassen AK, Andersson B, Gude E, et al
    Effect of Calcineurin Inhibitor-Free Everolimus-Based Immunosuppressive Regimen on Albuminuria and Glomerular Filtration Rate after Heart Transplantation.
    Transplantation. 2017 Feb 23. doi: 10.1097/TP.0000000000001706.
    PubMed     Abstract available


  95. LI C, Zhang LM, Zhang X, Huang X, et al
    Short-term Pharmacological Inhibition of MyD88 Homodimerization by a Novel Inhibitor Promotes Robust Allograft Tolerance in Mouse Cardiac and Skin Transplantation.
    Transplantation. 2017;101:284-293.
    PubMed     Abstract available


  96. CHOUDHURY RA, Reese PP, Goldberg DS, Bloom RD, et al
    A Paired Kidney Analysis of Multiorgan Transplantation: Implications for Allograft Survival.
    Transplantation. 2017;101:368-376.
    PubMed     Abstract available


    January 2017
  97. NEUMANN A, Napp LC, Kleeberger JA, Benecke N, et al
    MicroRNA 628-5p as a Novel Biomarker for Cardiac Allograft Vasculopathy.
    Transplantation. 2017;101:e26-e33.
    PubMed     Abstract available


  98. GU G, Huang Y, Wu C, Guo Z, et al
    Differential Expression of Long Noncoding RNAs During Cardiac Allograft Rejection.
    Transplantation. 2017;101:83-91.
    PubMed     Abstract available


  99. AZIMZADEH AM, Zhang T, Wu G, Kelishadi SS, et al
    Preemptive CD20+ B cell Depletion Attenuates Cardiac Allograft Vasculopathy in CD154-Treated Monkeys.
    Transplantation. 2017;101:63-73.
    PubMed     Abstract available


  100. KRANSDORF EP, Kobashigawa JA
    Biomarkers for Cardiac Allograft Vasculopathy: Still Searching After All These Years.
    Transplantation. 2017;101:28-29.
    PubMed    


  101. KENNEDY C, Counihan A, Magee C
    Transplantation in Ireland.
    Transplantation. 2017;101:1-4.
    PubMed    


    December 2016
  102. BENKE K, Sayour AA, Matyas C, Agg B, et al
    Heterotopic Abdominal Rat Heart Transplantation as a Model to Investigate Volume Dependency of Myocardial Remodeling.
    Transplantation. 2016.
    PubMed     Abstract available


    August 2016
  103. FINE NM, Kushwaha SS
    RECENT ADVANCES IN MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR USE IN HEART AND LUNG TRANSPLANTATION.
    Transplantation. 2016.
    PubMed     Abstract available


    March 2016
  104. VANDEKERCKHOVE K, Coomans I, De Bruyne E, De Groote K, et al
    Evaluation of Exercise Performance, Cardiac Function, and Quality of Life in Children After Liver Transplantation.
    Transplantation. 2016.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Heart Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: